INDEGENE - A potential recent IPO listed pick
Updated
A life sciences commercialization company, recently listed in may'24. Company has
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
Trade active
A proxy for life sciences/pharma cos investment!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.